Skip to main content

In Vitro Genotoxicity Assessment and the Effects of 4-Quinolones upon Human Cells

  • Chapter
The 4-Quinolones: Anti Bacterial Agents in Vitro

Part of the book series: Springer Series in Applied Biology ((SSAPPL.BIOLOGY))

  • 67 Accesses

Abstract

The last five years have seen the emergence of several new derivatives of Nalidixic acid which display great antibacterial potency and broad-spectrum antibacterial activity. Recent national and international meetings have clearly demonstrated that this group of compounds, known collectively as the 4-quinolones, are at present the most intensively studied group of antibacterial chemotherapeutic agents. Evidence is rapidly accumulating which suggests that these agents have the potential to become amongst the most exciting and challenging clinical agents to enter clinical use since the advent of the ß-lactams. The 4-quinolones act through a uniquely complex mechanism of action upon DNA topoisomerases. These enzymes control the spatial geometry of the cellular DNA and in molecular biology they are providing new insights into how cells perform the routine mechanical tasks of replicating DNA and transcribing the genetic information. It is becoming increasingly evident that the DNA topoisomerases are fundamentally important in sustaining the normal life-processes of all cellular organisms from the simple bacterium through to Homo sapiens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ames BN, McCann J and Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test Mutat Res 31:347–364

    PubMed  CAS  Google Scholar 

  • Ashby J, Styles JA and Paton D (1980) Studies in vitro to discern structural requirements for carcinogenicity in analogues of the carcinogen 4-dimethylaminoazobenzene (butter yellow). Carcinogenesis 1:1–7

    Article  PubMed  CAS  Google Scholar 

  • Barrett JF, Gootz TD, McGuirck PR, Farrell C, Sokolowski S and Frescura M (1987) Use of in vitro topoisomerase II assays in studying nalidixic acid derivatives. XXV ICAAC (New York)

    Google Scholar 

  • Birkett DA, Garrett M and Stevenson CJ (1969) Phototoxic buUous eruptions due to Nalidixic acid. Brit J Dermatol 81:324–344

    Article  Google Scholar 

  • Bond CM (1988) Studies of DNA topoisomerases of human origin PhD Thesis University of York) Burry JN (1974) Persistent phototoxicity due to Nalidixic acid.Arch Dermatol 109:263

    Google Scholar 

  • Cairns J (1981) The origin of human cancers.Nature 289:353–357

    Article  PubMed  CAS  Google Scholar 

  • Chao L (1978) An unusual interaction between the target of nalidixic acid and novobiocin. Nature 271:385–386

    Article  PubMed  CAS  Google Scholar 

  • Chow K-C and Pearson GD (1985) Adenovirus infection elevates levels of cellular topoisomerase I Proc Nad Acad Sci 82:2247–2251

    Article  CAS  Google Scholar 

  • Clive D, Flamm WG, Machesko MR and Bernheim NJ (1972) A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat Res 16:77–87

    Article  PubMed  CAS  Google Scholar 

  • Clive D and Spector JFS (1975) Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutat Res. 31 17–29

    PubMed  CAS  Google Scholar 

  • Cook TM, Goss WA and Deitz WH (1966) Mechanism of action of Nalidixic acid on Escherichia coli V Possible mutagenic effect. J Bacteriol 91:780–783

    PubMed  CAS  Google Scholar 

  • Crumplin GC(1981) The involvement of DNA topoisomerases in DNA repair and mutagenisis. Carcinogenisis 2:157–160

    Article  CAS  Google Scholar 

  • Crumplin GC (1985) The mechanisms of action of 4-quinolone antibacterials. ASM annual meeting (Las Vegas)

    Google Scholar 

  • Crumplin GC and Smith JT (1975) Nalidixic acid: an antibacterial paradox Antimicrob. Ag. Chemother 8:251–261

    CAS  Google Scholar 

  • Crumplin GC and Smith JT (1981) The effect of R factors on host cell responses to Nalidixic acid: I Increased susceptibility of Nalidixic acid sensitive hosts. Antimicrob Chemother 7:379–388

    Article  CAS  Google Scholar 

  • Czinn S J, Speck WT and Rosenkranz HS (1981) Abnormalities in the development of the American sea urchin induced by Nalidixic acid. Mutat Res.91:l19–121

    Article  Google Scholar 

  • Degnen GE (1974) A conditional mutator gene, MutD, in Escherichia coli. PhD Thesis Princeton University

    Google Scholar 

  • De Marini DM, Brock KL, Doerr CL and Moore MM (1986) Mutagenicity of topoisomerase II active drugs due to clastogenic mechanisms.First Conference on DNA topoisomerases in cancer chemotherapy (New York Nov 19–20)

    Google Scholar 

  • Domagala JM, Hanna LD, Heifitz CL, Hutt MP, Mich TF and Solomon P (1986) New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. J Med Chem 29:394–404

    Article  PubMed  CAS  Google Scholar 

  • Eamshaw WC and Heck MMS (1985) Localization of topoisomerase E in mitotic chromosomes. J Cell Biology 100:1716–1725

    Article  Google Scholar 

  • Earnshaw WC, Halligan B, Cooke CA, Heck MMS and Liu LF (1985) Topoisomerase II is a structural component of mitotic chromosome scaffolds. J Cell Biology 100:1706–1715

    Article  CAS  Google Scholar 

  • Easmon CSF and Crane JP (1985) Uptake of ciprofloxacin by macrophages. J Clin Pathol 38:442–444

    Article  PubMed  CAS  Google Scholar 

  • Easmon CSF and Crane J (1986) Uptake of Ro 23–6420 by phagocytic cells XXVIth ICAAC (New Orleans) abstr 947

    Google Scholar 

  • Echols H (1981) SOS functions, cancer and inducible evolution. Cell 25:1–2

    Article  PubMed  CAS  Google Scholar 

  • Firkin FC and Clark-Walker GD (1979) Abnormal mitochondrial DNA in acute leukaemia and lymphoma, Brit J Haematol 43:201–206

    Article  CAS  Google Scholar 

  • Furth EE, Thmy WG, Penman BW, Liber HL and R and WM (1981) Quantitative assay for mutation in diploid human lymphoblasts using microtitre plates. Analyt Biochem 110:1–8

    Article  PubMed  CAS  Google Scholar 

  • Garner RC (1980) In vitro assays to predict carcinogenicity? In Short-term test systems for detecting carcinogens, (eds. KH Norpoth and RC Gamer) pub. Springer-Verlag pp 5–18

    Chapter  Google Scholar 

  • German A, Panouse-Perrin J and Ardouin AC (1969) Mutagenic action of Nalidixic acid on Staphylococcus phage.CR Acad Sci Paris 268:1827–1829

    CAS  Google Scholar 

  • Green MHL and Muriel WJ (1976) Mutagen testing using trp + reversion in Escherichia coli Mutat Res 38:3–32

    Google Scholar 

  • Green MHL and Muriel WJ (1976) Mutagen testing using trp + reversion in Escherichia coli Mutat Res 38:3–32

    PubMed  CAS  Google Scholar 

  • Hartley HO and Sielken RL (1977) Estimation of “Safe Doses” in carcinogenic experiments. Biometrics 33:1–30

    Article  PubMed  CAS  Google Scholar 

  • Holden HE, Barrett JF, Huntington CM, Muehlbauer PA and Wahrenburg MG (1989) Genetic profile of a naidixic acid analog: A model for the mechanism of sister chromatid exchange induction.Environmental Mutagenesis 13:(in press)

    Google Scholar 

  • Hosomi J and Irikura T (1981) The mutagenicity of AM-715 in vitro.Chemotherapy 29 (S-4):938–945

    Google Scholar 

  • Hosomi J, Maeda A, Oomori Y, Irikura T and Yokota T (1988) Mutagenicity of norfloxacin and AM-833 in bacteria and mammalian cells Rev Infect Dis. 10 (suppl. 1):S148

    Google Scholar 

  • Bceda S, Yazawa M and Nishimura C (1987) Antiviral activity and inhibition of topoisomerase by Ofloxacin, a new quinolone derivative. Antiviral Research 8:103–113

    Article  Google Scholar 

  • Irikura T, Suzuki H and Sugimoto T (1981) Mutagenicity studies of AM-715 in animals Chemotherapy 29 (S-4);932–937

    CAS  Google Scholar 

  • Itoh T and Tomizawa J-I (1977) Involvement of DNA gyrase in bacteriophage T7 DNA replication.Nature 270:78–80

    Article  PubMed  CAS  Google Scholar 

  • Kada T and Hirano K (1980) Screening of environmental chemical mutagens by the rec assay system with Bacillus subtil is.in Chemical mutagens Principles and methods for their detection vol.6, (ed FJ de Serres) pub Plenum Press: 149–173

    Google Scholar 

  • Kanisawa M, Katoh H and Aiso K (1974) Carcinogenicity of potassium l-methyl-7-[2-(5-nitro-2-furyl)-vinyl] -4-oxo-l,4-dihydro-l,8-naphthyridine-3-carboxylate in ICR mice.Gann 65:1–11

    PubMed  CAS  Google Scholar 

  • Kohn KW (1979) DNA as a target in cancer chemotherapy: Measurement of macromolecular DNA damage produced in mammalian cells by anticancer agents and carcinogens.In Methods in Cancer Research Vol. XVL (Academic Press):291–345

    Google Scholar 

  • Kowalczyk J (1980) Sister chromatid exchanges in children treated with Nalidixic acid. Mutat Res 77:371–375

    Article  PubMed  CAS  Google Scholar 

  • Kreuzer KN, McEntee K, Geballe AP and Cozzarelli NR (1978) Lambda-transducing phages for the nalA gene of E. coli and conditional lethal mutations. Molec Gen Genet:167:129–137

    Article  PubMed  CAS  Google Scholar 

  • Latt SA and Schreck RR (1980) Sister chromatid exchange analysis. Amer J Hum Genet 32:297–313

    PubMed  CAS  Google Scholar 

  • Lode H, Hoffken G, Prinzing C, Glatzel P, Wiley R, Olschewski P, Sievers B, Reimnitz D, Borner K and Koeppe P (1987) Comparative pharmacokinetics of new 4-quinolones. Drugs 34:(Suppl.l) 21–25

    Article  PubMed  CAS  Google Scholar 

  • Louis P, Wiskemann A and Schulz KH (1973) Bullous Photodermatitis following Nalidixic acid. Hautaitz 24:445–448

    CAS  Google Scholar 

  • Marians KJ, Bceda J-E, Schlagman S. and Hurwitz J (1978) Role of DNA gyrase in FX replicative form replication in vitro Proc Natl Acad Sci 74: 1965–1968

    Article  Google Scholar 

  • Martin CN, McDermid AC and Garner RC (1977) Measurement of unscheduled DNA synthesis in HeLa cells by liquid scintillation counting after carcinogen treatment.Cancer Letters 2:355–360

    Article  PubMed  CAS  Google Scholar 

  • Martin CN, McDermid AC and Gamer RC (1978) Testing of known carcinogens and non-carcinogens for their ability to induce unscheduled DNA synthesis in HeLa cells. Cancer Res 38:2621–2627

    PubMed  CAS  Google Scholar 

  • Mattem MR and Scudiero DA (1981) Dependence of mammalian DNA synthesis on DNA supercoüing. IQ Characterization of the inhibition of replicative and repair-type DNA synthesis by novobiocin and Nalidixic acid. Biochim Biophys Acta 653: 248–258

    Google Scholar 

  • Maura A and Pino A (1988) Evaluation of the DNA-damaging and mutagenic activity of oxolinic and Pipemidic acids by the granuloma pouch assay. Mutagenisis (in press)

    Google Scholar 

  • Mayer D and Bruch K (1985) Kein hin weis fur mutagenitat von ofloxacin. Infection (in press)

    Google Scholar 

  • McChesney EW, Froelich EJ, Lesher GY,Crain AVR and Rosi D (1964) Absorption, excretion and metabolism of a new antibacterial agent, Nalidixic acid.Toxicol. App Pharmacol 6:292–309

    Article  CAS  Google Scholar 

  • McCoy EC, Petnülo LA and Rosenkranz HS (1980) Non-mutagenic genotoxicants: Novobiocin and Nalidixic acid, two inhibitors of DNA gyrase. Mutat Res 79:33–43

    Article  PubMed  CAS  Google Scholar 

  • McDaniel LS, Rogers LH and Hill WE (1980) Survival of recombination deficient mutants of Escherichia coli during incubation with Nalidixic acid. J Bacteriol 134:1195–1198

    Google Scholar 

  • McQueen CA. and Williams GA (1987) Effects of quinolone antibiotics in tests for genotoxicity.Amer J Med 82, Suppl 4A:94–96

    Google Scholar 

  • Melcion C and Cordier A (1986) Absence of genotoxicity of quinolones to mammalian cells.Intemational Symp New Quinolones (Geneva)

    Google Scholar 

  • Miltenberger HC (1985) cited in: Ofloxacin: Keine Anhaltspunkte fur mutagene Wirkungen.Arztliche Praxis 37:3482

    Google Scholar 

  • Mirkin SM, Zaitsev EN, Panyutin IG and Lyamichev VI (1984) Native supercoüing of DNA: The effects of DNA gyrase and ω protein in E. coli Molec Gen Genet 196:508–512

    Article  PubMed  CAS  Google Scholar 

  • Mizuuchi K, Geliert M and Nash HA (1978) Involvement of supertwisted DNA in integrative recombination of bacteriophage lambda J Molec Biol 121:375–392

    Article  PubMed  CAS  Google Scholar 

  • Moreau P and Devoret R (1977) Potential carcinogens tested by induction and mutagens of prophage λ In Escherichia coli K12.In Origins of human cancer book C (eds HH Hiatt and JD Watson) Pub Cold Spring Harbor Labs: 1451–1472

    Google Scholar 

  • Morita J, Watanabe K and Komano T (1984) Mechanism of action of new synthetic nalidixic acid-related antibiotics: Inhibition of DNA supercoiling catalyzed by DNA gyrase.Agric Biol Chem 48:663–668

    Article  CAS  Google Scholar 

  • Phillips I, Culebras E, Moreno F and Baquero F (1987) Induction of SOS response by 4-quinolones.J Antimicrob Chemother 20:631–638

    Article  PubMed  CAS  Google Scholar 

  • Priel E, Aboud M, Feifelman H and Segal S (1985) Topoisomerase II activity in human leukemic and lymphoblastoid cells. Biochem Biophys Res. Comm 130:325–332

    Article  PubMed  CAS  Google Scholar 

  • Ramsay CA and Obreshkova E (1974) Photosensitivity from Nalidixic acid. Br J Dermatol 91:523–528

    Article  PubMed  CAS  Google Scholar 

  • Ratcliffe NR (1985) Bacterial responses to antigyral agents. PhD Thesis University of London

    Google Scholar 

  • Ratcliffe NR and Smith JT (1984) The mechanism of reduced activity of 4-quinolone agents in urine. FAC:563–569

    Google Scholar 

  • Rosenkranz HS and Lambek C (1965) In vivo effects of nalidixic acid on the DNA of human diploid cells in tissue culture. Proc Soc Exp Biol Med 120:549–552

    PubMed  CAS  Google Scholar 

  • Rosenkranz HS and Leifer Z (1980) Detection of carcinogens and mutagens with repair-deficient bacteria. In Chemical mutagens — Principles and methods for their detection vol.6 (ed FJ.de Serres) Plenum press:109–147

    Google Scholar 

  • Saito A, Sawatari K, Fukuda Y, Nagasawa M, Koga H, Tomonaga A, Nakazato H, Fujita K, Shigeno Y, Suzuyama Y, Yamguchi K, Izumikawa K and Hara K (1985) Susceptibility of Legionella pneumophila to Ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.Antimicrob Ag Chemother 28:15–20

    CAS  Google Scholar 

  • Sanzey B (1979) Modulation of gene-expression by drugs affecting DNA gyrase. J Bacteriol 138:40–47

    PubMed  CAS  Google Scholar 

  • Schlüter G (1986) Toxicology of Ciprofloxacin, Proc. First Int. Ciprofloxacin Workshop (eds HC Neu and H Weuta) pp 61–67 (pub. Exerpta Medica, Amsterdam)

    Google Scholar 

  • Shen LL and Pernet AG (1985) Mechanism of inhibiton of DNA gyrase by analogues of Nalidixic acid: The target of the drug is DNA. Proc Natl Acad Sci 82:307–311

    Article  PubMed  CAS  Google Scholar 

  • Shimada H, Morita H and Akimoto T (1980) Lack of induction of dominant lethal mutations in male mice by Nalidixic acid. Mutat Res 7:165–170

    CAS  Google Scholar 

  • Shimada H, Ebine Y, Kurosawa Y and Aranchi T (1984) Mutagenicity studies of DL-8280, a new antibacterial drug.Chemotherapy 32:1162–1170

    CAS  Google Scholar 

  • Shimada H, Ebine Y, Kurosawa Y and Aranchi T (1985) Dominant lethal study in male mice treated with ofloxacin, a new antibacterial drug. Mutat Res 114:51–55

    Article  Google Scholar 

  • Smith CL, Kubo M and Imamato F (1978) Promoter specific inhibition of transcription by antibiotics which act on DNA gyrase. Nature 275:420–423

    Article  PubMed  CAS  Google Scholar 

  • Smith JT (1984) Awakening the slumbering potential of the 4-quinolone antibacterials. Pharm J 233:299–305

    CAS  Google Scholar 

  • Stenchever MA, Powell W and Jarvis JA (1970) Effects of Nalidixic acid on human chromosome integrity. Amer J Obstet Gynaec 107:329–330

    CAS  Google Scholar 

  • Stevens PJE (1980) Bactericidal effect against E. coli of Nalidixic acid and four structurally related compounds. J Antimicrob Chemother 6:535–542

    Article  PubMed  CAS  Google Scholar 

  • Styles JA (1977) A method for detecting carcinogenic organic chemicals using mammalian cells in culture. Brit J Cancer 36:558–563

    Article  PubMed  CAS  Google Scholar 

  • Tokunaga Y, Asaba M and Kato R (1979) Dominant lethal mutation test of Miloxacin, a new synthetic antibacterial agent. Pharmacometrics 18:37–45

    CAS  Google Scholar 

  • Vigier PRR (1974) Effet mutagene de l’acide nalidixique sur le bacteriophage T4.Mutat Res 25:25–32

    Article  PubMed  CAS  Google Scholar 

  • Winshell EB and Rosenkranz HS (1970) Nalidixic acid and the metabolism of Escherichia coli J Bacteriol 104:1168–1175

    PubMed  CAS  Google Scholar 

  • Witkin EM and Wermundsen IE (1979) Targeted and untargetedmutagenesis by various inducers of SOS functions in Escherichia coli Cold Spring Harbor Symp Quant Biol 43:881–886

    Article  PubMed  CAS  Google Scholar 

  • Zelickson AS (1964) Phototoxic reactions with Nalidixic acid. J Amer Med Ass 190:556–557

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag London Limited

About this chapter

Cite this chapter

Crumplin, G.C. (1990). In Vitro Genotoxicity Assessment and the Effects of 4-Quinolones upon Human Cells. In: Crumplin, G.C. (eds) The 4-Quinolones: Anti Bacterial Agents in Vitro. Springer Series in Applied Biology. Springer, London. https://doi.org/10.1007/978-1-4471-3449-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3449-7_12

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-3451-0

  • Online ISBN: 978-1-4471-3449-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics